Spread the love

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, MiRNA-based therapy for Neurodegerative diseases: MiRNA-125b inhibits ageing-associated cognitive decline and neurodegeneration via down regulation of its target gene, 18/January/20145, 21.35, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: This study suggests, for the first time, that MiRNA-125b, by decreasing the expression of its target gene, it may inhibit ageing-associated cognitive decline and neurodegeneration. Thus, pharmacological formulations encompassing “miR-125 activators”  may be used to inhibit ageing-associated cognitive decline and neurodegeneration.

Amount: $ 300

Undisclosed information: How MiRNA-125b inhibits ageing-associated cognitive decline and neurodegeneration

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation


Spread the love